Free Trial

Jay K. Kunkel Sells 2,575 Shares of VAREX IMAGING (NASDAQ:VREX) Stock

VAREX IMAGING logo with Medical background

VAREX IMAGING (NASDAQ:VREX - Get Free Report) Director Jay K. Kunkel sold 2,575 shares of the company's stock in a transaction that occurred on Wednesday, June 18th. The stock was sold at an average price of $7.77, for a total transaction of $20,007.75. Following the completion of the sale, the director now directly owns 22,477 shares of the company's stock, valued at approximately $174,646.29. This represents a 10.28% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.

VAREX IMAGING Stock Up 1.0%

VAREX IMAGING stock traded up $0.08 during trading hours on Friday, hitting $7.75. The company had a trading volume of 1,422,137 shares, compared to its average volume of 584,013. The firm has a market capitalization of $319.30 million, a P/E ratio of -7.52 and a beta of 0.66. The company has a debt-to-equity ratio of 1.00, a current ratio of 4.05 and a quick ratio of 2.36. The firm's fifty day moving average is $7.96 and its 200-day moving average is $11.40. VAREX IMAGING has a fifty-two week low of $6.76 and a fifty-two week high of $16.93.

VAREX IMAGING (NASDAQ:VREX - Get Free Report) last posted its earnings results on Thursday, May 8th. The company reported $0.26 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.14 by $0.12. The business had revenue of $212.90 million for the quarter, compared to analyst estimates of $206.76 million. VAREX IMAGING had a negative net margin of 5.08% and a positive return on equity of 4.91%. VAREX IMAGING's revenue was up 3.3% compared to the same quarter last year. During the same period last year, the business posted $0.16 EPS. On average, research analysts forecast that VAREX IMAGING will post 0.53 earnings per share for the current year.

Analyst Upgrades and Downgrades

VREX has been the subject of a number of research analyst reports. B. Riley raised shares of VAREX IMAGING to a "strong-buy" rating in a research note on Monday, May 12th. Wall Street Zen lowered shares of VAREX IMAGING from a "strong-buy" rating to a "buy" rating in a research note on Thursday, May 22nd.

Get Our Latest Analysis on VAREX IMAGING

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Allspring Global Investments Holdings LLC lifted its stake in VAREX IMAGING by 21.0% in the first quarter. Allspring Global Investments Holdings LLC now owns 2,779,412 shares of the company's stock valued at $31,769,000 after buying an additional 481,537 shares in the last quarter. Vanguard Group Inc. lifted its stake in VAREX IMAGING by 4.2% in the first quarter. Vanguard Group Inc. now owns 2,640,127 shares of the company's stock valued at $30,625,000 after buying an additional 106,412 shares in the last quarter. Cooke & Bieler LP lifted its stake in VAREX IMAGING by 18.7% in the first quarter. Cooke & Bieler LP now owns 2,122,683 shares of the company's stock valued at $24,623,000 after buying an additional 333,794 shares in the last quarter. Wellington Management Group LLP lifted its position in shares of VAREX IMAGING by 5.9% in the first quarter. Wellington Management Group LLP now owns 1,545,829 shares of the company's stock worth $17,932,000 after purchasing an additional 86,350 shares in the last quarter. Finally, Wealthfront Advisers LLC bought a new stake in shares of VAREX IMAGING in the fourth quarter worth $18,900,000.

VAREX IMAGING Company Profile

(Get Free Report)

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Varex Imaging Right Now?

Before you consider Varex Imaging, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Varex Imaging wasn't on the list.

While Varex Imaging currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Congress Bought This Stock at the Bottom—Will You Miss It?
The Drone Industry Is About to 10X—Here’s How to Profit
Why AMD Stock Beats NVIDIA Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines